These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38571690)

  • 21. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
    Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
    Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema.
    Sun F; Hall A; Tighe MP; Brunelle CL; Sayegh HE; Gillespie TC; Daniell KM; Taghian AG
    Breast Cancer Res Treat; 2018 Nov; 172(1):83-91. PubMed ID: 30062571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention.
    Ridner SH; Dietrich MS; Boyages J; Koelmeyer L; Elder E; Hughes TM; French J; Ngui N; Hsu J; Abramson VG; Moore A; Shah C
    Lymphat Res Biol; 2022 Dec; 20(6):618-628. PubMed ID: 35099283
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines.
    Shah C; Vicini FA; Arthur D
    Breast J; 2016 Nov; 22(6):645-650. PubMed ID: 27487985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Bioimpedance Spectroscopy and Magnetic Resonance Lymphangiography in the Diagnosis and Assessment of Lymphedema.
    Varagur K; Shetty AS; Saoud K; Ochoa E; Skladman R; Skolnick GB; Sacks JM; Christensen JM
    J Reconstr Microsurg; 2024 Mar; 40(3):177-185. PubMed ID: 37236242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
    Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
    Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema.
    Seward C; Skolny M; Brunelle C; Asdourian M; Salama L; Taghian AG
    J Surg Oncol; 2016 Oct; 114(5):537-542. PubMed ID: 27393376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
    Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
    Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioimpedance spectroscopy is not associated with a clinical diagnosis of breast cancer-related lymphedema.
    Spitz JA; Chao AH; Peterson DM; Subramaniam V; Prakash S; Skoracki RJ
    Lymphology; 2019; 52(3):134-142. PubMed ID: 31874125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements.
    Borman P; Yaman A; Doğan L; Arıkan Dönmez A; Koyuncu EG; Balcan A; Aksoy S; Özaslan C; Akın R; Üneş K
    Eur J Breast Health; 2022 Apr; 18(2):148-154. PubMed ID: 35445173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity.
    Fu MR; Cleland CM; Guth AA; Kayal M; Haber J; Cartwright F; Kleinman R; Kang Y; Scagliola J; Axelrod D
    Lymphology; 2013 Jun; 46(2):85-96. PubMed ID: 24354107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manual lymphatic drainage for lymphedema following breast cancer treatment.
    Ezzo J; Manheimer E; McNeely ML; Howell DM; Weiss R; Johansson KI; Bao T; Bily L; Tuppo CM; Williams AF; Karadibak D
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003475. PubMed ID: 25994425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determining the precision of dual energy x-ray absorptiometry and bioelectric impedance spectroscopy in the assessment of breast cancer-related lymphedema.
    Newman AL; Rosenthall L; Towers A; Hodgson P; Shay CA; Tidhar D; Vigano A; Kilgour RD
    Lymphat Res Biol; 2013 Jun; 11(2):104-9. PubMed ID: 23772720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative Assessment of Upper Extremity Secondary Lymphedema.
    Wiser I; Mehrara BJ; Coriddi M; Kenworthy E; Cavalli M; Encarnacion E; Dayan JH
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935796
    [No Abstract]   [Full Text] [Related]  

  • 36. A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months Postoperatively.
    Ridner SH; Dietrich MS; Spotanski K; Doersam JK; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder S; Shah C; Vicini F
    Lymphat Res Biol; 2018 Oct; 16(5):435-441. PubMed ID: 30130147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
    Ridner SH; Dietrich MS; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder SM; Wagner J; Abramson V; Moore A; Shah C
    Ann Surg Oncol; 2019 Oct; 26(10):3250-3259. PubMed ID: 31054038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema.
    Barrio AV; Eaton A; Frazier TG
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S370-5. PubMed ID: 26085222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioimpedance in the assessment of unilateral lymphedema of a limb: the optimal frequency.
    Gaw R; Box R; Cornish B
    Lymphat Res Biol; 2011; 9(2):93-9. PubMed ID: 21688978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Diagnostic Tools for Breast Cancer-Related Lymphedema.
    Shah C; Asha W; Vicini F
    Curr Oncol Rep; 2023 Mar; 25(3):151-154. PubMed ID: 36696076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.